Applied Therapeutics, Inc. Shareholders' Equity
Applied Therapeutics, Inc. had Shareholders' Equity of -$561.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2025-11-13
- 2025-09-30: Stockholders' Equity Attributable to Parent -$561.00K.
- 2025-06-30: Stockholders' Equity Attributable to Parent $17.44M.
- 2025-03-31: Stockholders' Equity Attributable to Parent $36.67M.
- 2024-12-31: Stockholders' Equity Attributable to Parent $57.01M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2025-09-30 | -$561.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $17.44M 10-Q · filed 2025-11-13 | |
| 2025-03-31 | $36.67M 10-Q · filed 2025-11-13 | |
| 2024-12-31 | $57.01M 10-Q · filed 2025-11-13 | |
| 2024-09-30 | $5.89M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $72.39M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $67.29M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | -$17.15M 10-Q · filed 2025-11-13 | |
| 2023-09-30 | -$11.04M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | -$4.33M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | -$4.07M 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $4.06M 10-K · filed 2025-04-15 | |
| 2022-09-30 | $9.63M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $25.81M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $41.96M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $62.54M 10-K · filed 2024-03-06 | |
| 2021-09-30 | $86.70M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $112.44M 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $135.22M 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $81.94M 10-K · filed 2023-03-23 | |
| 2020-09-30 | $102.94M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $130.20M 10-Q · filed 2021-11-12 | |
| 2020-03-31 | $155.83M 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $32.61M 10-K · filed 2022-03-10 | |
| 2019-09-30 | $30.75M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $40.00M 10-Q · filed 2020-11-12 | |
| 2019-03-31 | -$27.92M 10-Q · filed 2020-11-12 | |
| 2018-12-31 | -$19.59M 10-K · filed 2021-03-18 | |
| 2018-09-30 | -$13.57M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | -$9.40M 10-Q · filed 2019-11-13 | -$9.37M 10-Q · filed 2019-08-12 |
| 2018-03-31 | -$6.30M 10-Q · filed 2019-11-13 | -$6.27M 10-Q · filed 2019-06-21 |
| 2017-12-31 | -$3.96M 10-K · filed 2020-03-13 |